SG Americas Securities
SHPH icon

SG Americas Securities’s Shuttle Pharmaceuticals SHPH Stock Holding History

SG Americas Securities’s Portfolio SHPH Stock Details SHPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8
Closed -$33K – 3520
2022
Q4 		$33K Buy
+8
New +$38.9K ﹤0.01% 2890

Other funds holding SHPH

Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

SG Americas Securities's SHPH Position: Q1 2023 in Review

SG Americas Securities sold out of Shuttle Pharmaceuticals (SHPH) in Q1 2023, closing a stake of 8 shares — an estimated $33K sold.

SG Americas Securities first reported a position in SHPH in Q4 2022 and held it in 1 quarter. The position peaked at $33K in Q4 2022. 3 funds tracked by Wall St. Rank hold SHPH as of Q1 2023.

  • SG Americas Securities reported no remaining Shuttle Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • SG Americas Securities sold 8 Shuttle Pharmaceuticals shares in Q1 2023, an estimated $33K.
  • SG Americas Securities first reported a position in Shuttle Pharmaceuticals in Q4 2022 and held it in 1 quarter.
  • SG Americas Securities's Shuttle Pharmaceuticals position peaked at $33K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q1 2023.

Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.